Successful Case of Treatment the Patient with Synchronous Rectal and Sigmoid Cancers and Synchronous Lung Metastasis-Reference-Cited by-同舟云学术

Successful Case of Treatment the Patient with Synchronous Rectal and Sigmoid Cancers and Synchronous Lung Metastasis

Published:2021-07-20 Issue:3 Volume:66 Page:76-81
ISSN:1024-6177
Container-title:Medical Radiology and radiation safety
language:en
Short-container-title:

Author:

Polynovskiy A.¹,Kuz'michev D.¹,Mamedli Z.¹,Tkachev Sergey¹,Chernich M.²,Suraeva Yu.³,Madyarov J.¹,Aniskin A.²,Kolobanova E.²

Affiliation:

1. N.N. Blokhin National Medical Research Center of Oncology

2. N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia

3. PET-Technology, Podolsk, Moscow Region, Russia

Abstract

Colorectal cancers (CRC) takes the leading position in the incidence of morbidity and mortality worldwide. Metastatic CRC in the primary diagnosis ranges from 15 to 35 %. Lung metastasis are the most frequent extraperitoneal manifestation of the metastatic process. Such patients are relatively rare and there are no clear recommendations for their treatment tactics to date. This clinical case describes a successful strategy of using preoperative prolonged chemoradiotherapy on a primary tumor and stereotactic irradiation of lung metastasis, with courses of chemotherapy, with further radical laparoscopic operation, in a patient with disseminated primary multiple rectal cancer, synchronous sigmoid colon cancer and 2 metastatic focuses in both lungs.

Publisher

Infra-M Academic Publishing House

Subject

Nuclear Energy and Engineering

Reference44 articles.

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S. et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012; Eur J Cancer 2013;49(6):1374–403., Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S. et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012; Eur J Cancer 2013;49(6):1374–403.

2. Goldberg RM. Advances in the treatment of metastatic colorectal cancer. Oncologist. 2005; 10 Suppl 3:40–8., Goldberg RM. Advances in the treatment of metastatic colorectal cancer. Oncologist. 2005; 10 Suppl 3:40–8.

3. Zacharakis M, Xynos I.D, Lazaris A. et al. Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res. 2010;30(2):653–60., Zacharakis M, Xynos I.D, Lazaris A. et al. Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res. 2010;30(2):653–60.

4. Manfredi S, Lepage C, Hatem C, Coatmeur O. et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254–9., Manfredi S, Lepage C, Hatem C, Coatmeur O. et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254–9.

5. Nordholm-Carstensen A, Krarup PM, Jorgensen LN, Wille-Jorgensen PA, et al. On behalf of Danish colorectal Cancer group. Occurrence and survival of synchronous pulmonary metastases in colorectal cancer: a nationwide cohort study. Eur J Cancer. 2014; 50:447–56., Nordholm-Carstensen A, Krarup PM, Jorgensen LN, Wille-Jorgensen PA, et al. On behalf of Danish colorectal Cancer group. Occurrence and survival of synchronous pulmonary metastases in colorectal cancer: a nationwide cohort study. Eur J Cancer. 2014; 50:447–56.